Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
July 6th, 2023
New FTC Guidelines Could Prompt Marketers, Influencers to Revisit Endorsement Practices
Advertising Partner Jeffrey A. Greenbaum is quoted in the article, "New FTC Guidelines Could Prompt Marketers, Influencers to Revisit Endorsement Practices" published by The Wall Street Journal. The article discusses the new FTC guidelines for endorsements, which advises businesses on ensuring all users see that a post is sponsored clearly. Jeff is quoted saying, "The FTC has long accepted many of marketers’ standard disclosure methods as sufficient, but the new guidelines make clear that this is no longer the case by going into greater detail about what they must do to avoid potential penalties."
The updated guidelines offer additional details and specific points for influencers to disclose relationships with the brands they mention. Jeff notes, "For an online disclosure to be effective, it needs to be unavoidable [under the new guidelines]. This is a big change in terms of what advertisers are required to do.”
Read the full article here.
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
